Sarvetnick N - Search Results

1

Increasing the chemical potential of the germ-line antibody repertoire.

Sarvetnick N, Gurushanthaiah D, Han N, Prudent J, Schultz P, Lerner R. Sarvetnick N, et al. Proc Natl Acad Sci U S A. 1993 May 1;90(9):4008-11. doi: 10.1073/pnas.90.9.4008. Proc Natl Acad Sci U S A. 1993. PMID: 8483917 Free PMC article.

2

Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse.

Shi FD, Flodstrom M, Balasa B, Kim SH, Van Gunst K, Strominger JL, Wilson SB, Sarvetnick N. Shi FD, et al. Among authors: sarvetnick n. Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6777-82. doi: 10.1073/pnas.121169698. Proc Natl Acad Sci U S A. 2001. PMID: 11390999 Free PMC article.

3

Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy.

Kafri T, Morgan D, Krahl T, Sarvetnick N, Sherman L, Verma I. Kafri T, et al. Among authors: sarvetnick n. Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11377-82. doi: 10.1073/pnas.95.19.11377. Proc Natl Acad Sci U S A. 1998. PMID: 9736744 Free PMC article.

4

Viruses, cytokines, antigens, and autoimmunity.

Gianani R, Sarvetnick N. Gianani R, et al. Among authors: sarvetnick n. Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2257-9. doi: 10.1073/pnas.93.6.2257. Proc Natl Acad Sci U S A. 1996. PMID: 8637859 Free PMC article. Review.

5

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.

Dai Y, Schwarz EM, Gu D, Zhang WW, Sarvetnick N, Verma IM. Dai Y, et al. Among authors: sarvetnick n. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1401-5. doi: 10.1073/pnas.92.5.1401. Proc Natl Acad Sci U S A. 1995. PMID: 7877990 Free PMC article.

6

Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice.

Balasa B, Lee J, Sarvetnick N. Balasa B, et al. Among authors: sarvetnick n. Cell Immunol. 1999 May 1;193(2):170-8. doi: 10.1006/cimm.1999.1484. Cell Immunol. 1999. PMID: 10222059

7

The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes.

Balasa B, Van Gunst K, Sarvetnick N. Balasa B, et al. Among authors: sarvetnick n. Clin Immunol. 2000 May;95(2):93-8. doi: 10.1006/clim.2000.4855. Clin Immunol. 2000. PMID: 10779402

8

Sensitization to self (virus) antigen by in situ expression of murine interferon-gamma.

Lee MS, von Herrath M, Reiser H, Oldstone MB, Sarvetnick N. Lee MS, et al. Among authors: sarvetnick n. J Clin Invest. 1995 Feb;95(2):486-92. doi: 10.1172/JCI117689. J Clin Invest. 1995. PMID: 7860730 Free PMC article.

9

Postnatal anti-interferon-gamma treatment prevents pancreatic inflammation in transgenic mice with beta-cell expression of interferon-gamma.

Wogensen L, Molony L, Gu D, Krahl T, Zhu S, Sarvetnick N. Wogensen L, et al. Among authors: sarvetnick n. J Interferon Res. 1994 Jun;14(3):111-6. doi: 10.1089/jir.1994.14.111. J Interferon Res. 1994. PMID: 7930757

10

IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity.

Lee MS, Mueller R, Wicker LS, Peterson LB, Sarvetnick N. Lee MS, et al. Among authors: sarvetnick n. J Exp Med. 1996 Jun 1;183(6):2663-8. doi: 10.1084/jem.183.6.2663. J Exp Med. 1996. PMID: 8676087 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters